等待開盤 09-20 09:30:00 美东时间
+0.020
+0.55%
Pyxis Oncology press release (NASDAQ:PYXS): Q2 GAAP EPS of -$0.29. The Company ended the second quarter of 2024 with $157.2 million in cash, cash equivalents, restricted cash and short-term investment...
08-15 19:26
Gainers: Applied Optoelectronics (AAOI) +5%. Eliem Therapeutics (ELYM) +4%. Infinera Corporation (INFN) +4%. Harrow (HROW) +4%. Health Catalyst (HCAT) +4%. Losers: Eagle Pharmaceuticals (EGRX) -10%. D...
04-13 05:05
In a report released yesterday, Leonid Timashev from RBC Capital maintained a B...
03-22 18:38
Pyxis Oncology shares are trading lower. The company reported FY23 financial re...
03-22 00:26
Gainers: Nortech Systems (NSYS) +26%. Monogram Orthopaedics (MGRM) +18%. X4 Pharmaceuticals (XFOR) +15%. Jin Medical International Ltd (ZJYL) +15%. Argen (ARGX) +12%. Losers: Tourmaline Bio (TRML) -39...
03-21 22:12
Pyxis Oncology (NASDAQ:PYXS) reported its Q4 earnings results on Thursday, Marc...
03-21 21:30
Losers: Destination XL Group (DXLG) -16% after Q4 earnings release. Tourmaline Bio (TRML) -30%. Apyx Medical Corp (APYX) -17% after Q4 earnings release. Five Below (FIVE) -12% after Q4 earnings releas...
03-21 20:43
The latest update is out from Pyxis Oncology (PYXS). The Company has recently u...
03-21 20:02
一夜大涨121%!减肥药“新星”Viking成为资本新宠;太阳能和可再生能源公司SolarMax上市首日大涨100%;高途大涨30%,2023年现金收入33.39亿元>>
02-28 18:30
BOSTON, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: ...
02-27 21:00